TOP STORIES

• BUSINESS Will Pricing Reform Spur Divestment of Off-Patent Brands in Japan? Next 3 Months Hold Key for Future Directions
  January 1, 2018

• BUSINESS Sawai Shooting for 12.7% Annual Growth for Upsher-Smith: Exec
  December 27, 2017

• BUSINESS MHLW to Use Its Classification Table to Pick PMP-Eligible Similar Drugs; How Will 3 Year 3rd Product Rule Affect I/O and Other Meds?
  December 26, 2017

• REGULATORY “Comprehensive Strategy” Updated after 2 Years, MHLW to Mull Procedures for Info Handover for Brand-Name Meds Bowing Out of Market
  December 25, 2017

• ORGANIZATION JPMA to Call for Improvements in PMP-Eligibility Criteria, Company Requirements: Chief
  December 22, 2017

• REGULATORY Chuikyo OKs Drug Pricing Reform Package; 30% Cap Set for “Category I” Companies Allowed to Maintain Full Prices
  December 21, 2017

• BUSINESS GSK Japan Pres. Kikuchi to Quit after Only 9 Months in Office
  December 20, 2017

• BUSINESS Gilead Aiming to Develop World’s First NASH Treatment, Hoping for Approval in 2020
  December 20, 2017

• REGULATORY (Update) Japan to Shave 720 Billion Yen through FY2018 Drug Price Revision
  December 19, 2017

• REGULATORY Govt to Draw Up “Plan to Strengthen Drug Discovery,” Boosting Budgets to Improve R&D Environment
  December 18, 2017

• BUSINESS Partnerships Hold Key to Success, Acquisition Not Our Goal: Takeda R&D Head
  December 15, 2017

• REGULATORY Chuikyo Debate Intermitted as Members Fume at Political Arrangement, New PMP Plan Still Clears Panel with Strings Attached
  December 14, 2017

• REGULATORY Chuikyo Members Snub Possible Change to 14-Day Prescription Limit
  December 13, 2017

• BUSINESS Japan Drug Makers Driven by Overseas Sales, See Tepid Revenue at Home: Jiho Tally
  December 12, 2017

• REGULATORY MHLW Proposes Physician Fee for Proper Antibiotic Use in Children, Aims to Cut Unnecessary Use: Chuikyo
  December 11, 2017

• BUSINESS AbbVie Hopes Maviret Will Encourage Potential Hep C Patients to Get Treatment: Hepatitis Biz Head
  December 11, 2017

• REGULATORY Govt’s Modified PMP Plan: “1-Year Cutoff” Extended for 3 Years, 25% of Firms Could Now Maintain Full Prices
  December 8, 2017

• REGULATORY Easing of Proposed PMP Requirements Likely, Major Focus on “One-Year Cutoff” and “Category I” Scope
  December 7, 2017

• REGULATORY (Update) NHI-Market Drug Price Gap at 9.1%, 7.1% Regular Price Cut Expected in FY2018
  December 6, 2017

• REGULATORY NHI-Market Drug Price Gap at 9.1%, 7.1% Regular Price Cut Expected in FY2018
  December 6, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 124
• 125
• 126
• 127
• 128
• 129
• 130
• 131
• 132
• …
• Next ›
• 最終 »